Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen
(Q84539941)
scientific article published on 11 July 2011
scientific article published on 11 July 2011
Language:
Current Data About
Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen
other details
| description | scientific article published on 11 July 2011 |
External Links
| (P356) |
10.1093/ANNONC/MDR299
|
| (P698) |
21746804
|